ACADIA PHARMACEUTICA (ACAD) insider trading activity (SEC Form 4). Over the trailing 90 days, ACAD insiders filed 0 purchases totalling $0 and 4 sales totalling $1.4M — net SELLING of $1.4M. Most recent filing: Aug 7, 2026. Insider transactions are a Pro-tier alertable signal in the live Top Tier Newswire terminal — Form 4 filings reach the wire within minutes of acceptance by the SEC. Data shown publicly here is delayed 4 hours.
| Filed | Insider | Role | Type | Shares | Price | Value | |
|---|---|---|---|---|---|---|---|
| Aug 7, 2026 | Schneyer Mark C. | EVP, CFO | S SaleOE | — | $29.16 | $587K | filing |
| Jul 31, 2026 | Thompson Elizabeth H.Z. | EVP, Head of Research, Dev | S SaleOE | — | $26.13 | $433K | filing |
| Jun 29, 2026 | Kihara James | PRINCIPAL ACCOUNTING OFFICER | S Sale | — | $26.08 | $298K | filing |
| May 27, 2026 | Kihara James | PRINCIPAL ACCOUNTING OFFICER | S Sale | — | $21.18 | $114K | filing |